Nomura Holdings
BIO icon

Nomura Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Nomura Holdings’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6M Buy
328,897
+111,555
+51% +$31.6M 0.11% 106
2026
Q1 		$60.6M Buy
+217,342
New +$62.6M 0.16% 97
2025
Q1 		– Sell
-3,055
Closed -$1M – 1794
2024
Q4 		$1M Buy
+3,055
New +$1.04M ﹤0.01% 1466
2022
Q2 		– Sell
-512
Closed -$291K – 1825
2022
Q1 		$291K Buy
512
+8
+2% +$4.82K ﹤0.01% 1458
2021
Q4 		$381K Sell
504
-170
-25% -$127K ﹤0.01% 1616
2021
Q3 		$502K Buy
674
+63
+10% +$47.2K ﹤0.01% 1391
2021
Q2 		$394K Sell
611
-2,099
-77% -$1.28M ﹤0.01% 1472
2021
Q1 		$1.55M Buy
2,710
+1,908
+238% +$1.13M ﹤0.01% 944
2020
Q4 		$466K Buy
802
+271
+51% +$154K ﹤0.01% 1250
2020
Q3 		$273K Buy
+531
New +$269K ﹤0.01% 1146
2018
Q4 		– Sell
-1,568
Closed -$484K – 1202
2018
Q3 		$484K Buy
1,568
+867
+124% +$269K ﹤0.01% 1006
2018
Q2 		$202K Sell
701
-15,709
-96% -$4.34M ﹤0.01% 1191
2018
Q1 		$4.11M Sell
16,410
-29,263
-64% -$7.45M 0.01% 613
2017
Q4 		$10.9M Buy
+45,673
New +$11.1M 0.02% 430
2014
Q3 		– Sell
-2,123
Closed -$254K – 2769
2014
Q2 		$254K Buy
+2,123
New +$259K ﹤0.01% 2238

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nomura Holdings's BIO Position: Q2 2026 in Review

Nomura Holdings increased its Bio-Rad Laboratories Class A (BIO) stake by 51% in Q2 2026, buying an estimated $31.6M and bringing the position to 328,897 shares worth $96.6M. The position accounts for 0.11% of the portfolio, ranked #106.

Nomura Holdings first reported a position in BIO in Q2 2014 and has held it in 15 quarters since. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Nomura Holdings held 328,897 shares of Bio-Rad Laboratories Class A worth $96.6M as of Q2 2026.
  • Nomura Holdings bought 111,555 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $31.6M.
  • Bio-Rad Laboratories Class A made up 0.11% of Nomura Holdings's portfolio in Q2 2026, its #106 holding.
  • Nomura Holdings first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and has held it in 15 quarters since.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.